0.80
5.99%
-0.051
Scisparc Ltd 주식(SPRC)의 최신 뉴스
SciSparc Ltd. Enhances Loan Agreement with AutoMax - TipRanks.com - TipRanks
TipRanks
SciSparc Granted Patent for Core Technology in Multiple Jurisdictions in Europe - Quantisnow
Quantisnow
Ratio Review: Analyzing SciSparc Ltd (SPRC)'s Price-to-Cash and Price-to-Free Cash Flow – DWinneX - The Dwinnex
The Dwinnex
SciSparc Ltd. Secures European Patent Boost - TipRanks.com - TipRanks
TipRanks
SciSparc secures European patent for antimicrobial method - Investing.com India
Investing.com India
SciSparc Secures Strategic Advantage with Grant of European Patent - GlobeNewswire
GlobeNewswire
SPRC’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle
The InvestChronicle
SciSparc secures European patent for antimicrobial method By Investing.com - Investing.com
Investing.com
Understanding SPRC's book value per share for better investment insights – US Post News - US Post News
US Post News
SciSparc Secures Strategic Advantage with Grant of European Patent - GlobeNewswire
GlobeNewswire
SciSparc Secures Strategic Advantage with Grant of European Patent
GlobeNewswire Inc.
SciSparc secures European patent for antimicrobial method By Investing.com - Investing.com
Investing.com
SciSparc stock rallies 67% on positive results for Alzheimer's drug - MSN
MSN
SciSparc To Acquire AutoMax, A Strategic Leap Towards Industry Diversification - MSN
MSN
SPRC Stock Price and Chart — NASDAQ:SPRC - TradingView
TradingView
SciSparc stock rallies 67% on positive results for Alzheimer's drug - MSN
MSN
Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga
Why Macatawa Bank Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
Benzinga
SciSparc Announces Strategic Merger with Automax Motors - TipRanks
TipRanks
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga
SciSparc to Acquire AutoMax
GlobeNewswire Inc.
Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
Benzinga
SciSparc To Acquire AutoMax, A Strategic Leap Towards Industry Diversification - SciSparc (NASDAQ:SPRC) - Benzinga
Benzinga
SciSparc Advances Depression Treatment with New Patent - TipRanks.com - TipRanks
TipRanks
SciSparc- Clearmind Collaboration Evolves with New International Patent Application for Preventing and Treating Depression
GlobeNewswire Inc.
SciSparc- Clearmind Collaboration Evolves with New International Patent Application for Preventing and Treating ... - GlobeNewswire
GlobeNewswire
SciSparc: MitoCareX Unveils Groundbreaking Discovery of Small Molecule Structure in Anti-Cancer Research - GlobeNewswire
GlobeNewswire
SciSparc Granted Another Patent, Strengthening its Core Technology in Canada
GlobeNewswire Inc.
SciSparc Granted Another Patent, Strengthening its Core Technology in Canada - GlobeNewswire
GlobeNewswire
SciSparc Achieves Major Milestone with First Patient Dosed in Autism Spectrum Disorder Clinical Trial
GlobeNewswire Inc.
SciSparc doses first patient with CBD-containing drug in autism trial - Clinical Trials Arena
Clinical Trials Arena
SciSparc: MitoCareX Reveals Promising Results with Discovery of Novel Anti-Cancer Small Molecule Structure
GlobeNewswire Inc.
SciSparc: MitoCareX Reveals Promising Results with Discovery of Novel Anti-Cancer Small Molecule Structure - GlobeNewswire
GlobeNewswire
SciSparc Announces Enrollment of First Patient for its Clinical Trial for Children with Autism Spectrum Disorder
GlobeNewswire Inc.
SciSparc Announces Enrollment of First Patient for its Clinical Trial for Children with Autism Spectrum Disorder - GlobeNewswire
GlobeNewswire
SciSparc Granted Patent for Core Technology in Multiple Jurisdictions in Europe
GlobeNewswire Inc.
SciSparc secures Canadian patent for pain treatment By Investing.com - Investing.com India
Investing.com India
SciSparc Issued Canadian Patent for Opioids Reduction Use in Pain Management Technology
GlobeNewswire Inc.
SciSparc Issued Canadian Patent for Opioids Reduction Use in Pain Management Technology - GlobeNewswire
GlobeNewswire
SciSparc Delivers Treatment for Autism Spectrum Disorder Clinical Trial Enabling Commencement of Dosing
GlobeNewswire Inc.
SciSparc Delivers Treatment for Autism Spectrum Disorder Clinical Trial Enabling Commencement of Dosing - GlobeNewswire
GlobeNewswire
SciSparc says Clearmind files three new international patent applications - TipRanks.com - TipRanks
TipRanks
SciSparc says Clearmind files three new international patent applications - TipRanks.com - TipRanks
TipRanks
Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga
SciSparc and Clearmind Continue to Strengthen International Patent Portfolio with Next Generation Classic Psychedelic-Based Compounds
GlobeNewswire Inc.
Clearmind Medicine Submits Three International Patent Applications for Next Generation Classic Psychedelic-Based ... - Yahoo Finance
Yahoo Finance
SciSparc begins trial of therapy for autism spectrum disorder - Clinical Trials Arena
Clinical Trials Arena
SciSparc Announces Initiation of Patient Recruitment for its Clinical Trial with SCI-210 in Children with Autism Spectrum Disorder
GlobeNewswire Inc.
Why BlackBerry Shares Are Trading Lower By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga
Crude Oil Rises Over 1%; DuPont Shares Plunge
Benzinga
자본화:
|
볼륨(24시간):